Dalbeth, Nicola
Stamp, Lisa K.
Article History
First Online: 7 July 2015
Competing interests
: N.D. declares she has received consulting fees, speaker fees or grants from Ardea, AstraZeneca, Cymabay, Fonterra, Menarini, Metabolex, Pfizer, Savient, Takeda and Teijin. L.K.S. declares she has received consulting fees from AstraZeneca.